CRISPR Therapeutics AG
NASDAQ-GS: CRSP
.USD
-1.18 (2.16%)↓ today
Price at Feb 20, 4:00:01 PM EST • Market Closed
Loading...
Details
Valuations
Market Cap
Market Cap
Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"
Related Articles
5.13B
PEG Ratio
PEG Ratio
Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"
Related Articles
-12.85
Trailing P/E Ratio
Trailing P/E Ratio
Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"
Related Articles
-8.27
Forward P/E Ratio
Forward P/E Ratio
Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"
Related Articles
-12.85
Financial Performance
Revenue (TTM)
3.51M
Operating Cash Flow (TTM)
-345.01M
Net Profit Margin (TTM)
Net Profit Margin (TTM)
Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"
Related Articles
0.00%
Diluted EPS (TTM)
Diluted EPS (TTM)
Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"
Related Articles
-6.47
Cash
Total Cash (MRQ)
1.98B
Operating Free Cash Flow (TTM)
-345.01M
Levered Free Cash Flow (TTM)
-205.62M
Total Cash per Share (MRQ)
20.59
Advanced Valuations
Enterprise Value
3.36B
Enterprise Value to EBITDA
-6.13
Price-to-Sales (TTM)
Price-to-Sales (TTM)
Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"
Related Articles
1.46K
Price-to-Book (MRQ)
2.67
Balance Sheet
Total Debt (MRQ)
206.75M
Debt to Equity (MRQ)
10.76
Current Ratio (MRQ)
13.32
Book Value per Share (MRQ)
20.04
Detailed Financials
Revenue Growth (MRQ)
-97.60%
Earnings Growth (YOY)
-100.00%
Return on Equity (TTM)
-30.18%
Gross Profit Margin
Gross Profit Margin
Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"
Related Articles
0.00%
Share Information
Shares Outstanding
95.89M
Shares Float
92.40M
Beta
1.75
52-Week Range
30.04 - 78.48
Trading & Ownership
Institutional Ownership
76.62%
Insider Ownership
1.57%
Short Interest
25.78%
Average 90-Day Volume
1.71M
Dividends
Payout Ratio
0.00%
Forward Dividend Yield
0.00%
Ex. Dividend Date
Unknown
Dividend Date
Unknown
Indicators
Founder-Operated
No
Founder-operated companies generally perform better.
CEO
Samarth Kulkarni
Founders
Rodger Novak, Shaun Foy, Emmanuelle Charpentier
Industry Safety Score
1/5
Biotechnology
Net Profitability Score
2/5
As compared to these industry peers.
Loading...
Indicators
Founder-Operated
No
Founder-operated companies generally perform better.
CEO
Samarth Kulkarni
Founders
Rodger Novak, Shaun Foy, Emmanuelle Charpentier
Industry Safety Score
1/5
Biotechnology
Net Profitability Score
2/5
As compared to these industry peers.
Details
Valuations
Market Cap
Market Cap
Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"
Related Articles
5.13B
PEG Ratio
PEG Ratio
Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"
Related Articles
-12.85
Trailing P/E Ratio
Trailing P/E Ratio
Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"
Related Articles
-8.27
Forward P/E Ratio
Forward P/E Ratio
Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"
Related Articles
-12.85
Financial Performance
Revenue (TTM)
3.51M
Operating Cash Flow (TTM)
-345.01M
Net Profit Margin (TTM)
Net Profit Margin (TTM)
Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"
Related Articles
0.00%
Diluted EPS (TTM)
Diluted EPS (TTM)
Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"
Related Articles
-6.47
Cash
Total Cash (MRQ)
1.98B
Operating Free Cash Flow (TTM)
-345.01M
Levered Free Cash Flow (TTM)
-205.62M
Total Cash per Share (MRQ)
20.59
Advanced Valuations
Enterprise Value
3.36B
Enterprise Value to EBITDA
-6.13
Price-to-Sales (TTM)
Price-to-Sales (TTM)
Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"
Related Articles
1.46K
Price-to-Book (MRQ)
2.67
Balance Sheet
Total Debt (MRQ)
206.75M
Debt to Equity (MRQ)
10.76
Current Ratio (MRQ)
13.32
Book Value per Share (MRQ)
20.04
Detailed Financials
Revenue Growth (MRQ)
-97.60%
Earnings Growth (YOY)
-100.00%
Return on Equity (TTM)
-30.18%
Gross Profit Margin
Gross Profit Margin
Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"
Related Articles
0.00%
Share Information
Shares Outstanding
95.89M
Shares Float
92.40M
Beta
1.75
52-Week Range
30.04 - 78.48
Trading & Ownership
Institutional Ownership
76.62%
Insider Ownership
1.57%
Short Interest
25.78%
Average 90-Day Volume
1.71M
Dividends
Payout Ratio
0.00%
Forward Dividend Yield
0.00%
Ex. Dividend Date
Unknown
Dividend Date
Unknown